Letter to the Editor: ELF in the risk stratification of NAFLD-Are the ELF thresholds suggested by the AASLD guidelines appropriate?
- PMID: 37203218
- DOI: 10.1097/HEP.0000000000000464
Letter to the Editor: ELF in the risk stratification of NAFLD-Are the ELF thresholds suggested by the AASLD guidelines appropriate?
Comment in
-
Reply: ELF in the risk stratification of NAFLD-Are the ELF thresholds suggested by the AASLD guidelines appropriate?Hepatology. 2023 Dec 1;78(6):E103-E104. doi: 10.1097/HEP.0000000000000463. Epub 2023 May 19. Hepatology. 2023. PMID: 37199166 No abstract available.
Comment on
-
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.Hepatology. 2023 May 1;77(5):1797-1835. doi: 10.1097/HEP.0000000000000323. Epub 2023 Mar 17. Hepatology. 2023. PMID: 36727674 Free PMC article. No abstract available.
References
-
- Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, Kleiner DE, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77:1797–1835.
-
- Staufer K, Halilbasic E, Spindelboeck W, Eilenberg M, Prager G, Stadlbauer V, et al. Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease. United European. Gastroenterol J. 2019;7:1113–1123.
-
- Atellica IM Enhanced Liver Fibrosis (ELF). Rev. 02, 2023-01. https://www.siemens.healthineers.com
-
- Saarinen K, Färkkilä M, Jula A, Erlund I, Vihervaara T, Lundqvist A, et al. Enhanced liver Fibrosis® test predicts liver-related outcomes in the general population. JHEP Rep. 2023;5:100765.
-
- Vali Y, Lee J, Boursier J, Spijker R, Löffler J, Verheij J, et al. Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis. J Hepatol. 2020;73:252–262.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical